231 related articles for article (PubMed ID: 22107151)
61. First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes.
Feng M; Yang K; Wang J; Li G; Zhang H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675119
[TBL] [Abstract][Full Text] [Related]
62. Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells.
Zhao X; Liu Y; Du L; He L; Ni B; Hu J; Zhu D; Chen Q
Protein Cell; 2015 Feb; 6(2):127-38. PubMed ID: 25503443
[TBL] [Abstract][Full Text] [Related]
63. Pachastrissamine from Pachastrissa sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated FOXO3 downregulation.
Yoo H; Lee YS; Lee S; Kim S; Kim TY
Phytother Res; 2012 Dec; 26(12):1927-33. PubMed ID: 22451302
[TBL] [Abstract][Full Text] [Related]
64. Forkhead box O3 (FOXO3) transcription factor mediates apoptosis in BCG-infected macrophages.
Haoues M; Refai A; Mallavialle A; Barbouche MR; Laabidi N; Deckert M; Essafi M
Cell Microbiol; 2014 Sep; 16(9):1378-90. PubMed ID: 24712562
[TBL] [Abstract][Full Text] [Related]
65. Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major.
Thanuthanakhun N; Nuntakarn L; Sampattavanich S; Anurathapan U; Phuphanitcharoenkun S; Pornpaiboonstid S; Borwornpinyo S; Hongeng S
PLoS One; 2017; 12(11):e0187610. PubMed ID: 29099866
[TBL] [Abstract][Full Text] [Related]
66. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Maegawa S; Chinen Y; Shimura Y; Tanba K; Takimoto T; Mizuno Y; Matsumura-Kimoto Y; Kuwahara-Ota S; Tsukamoto T; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2018 Mar; 59():72-81.e2. PubMed ID: 29287939
[TBL] [Abstract][Full Text] [Related]
67. Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.
Yoshimura M; Ishizawa J; Ruvolo V; Dilip A; Quintás-Cardama A; McDonnell TJ; Neelapu SS; Kwak LW; Shacham S; Kauffman M; Tabe Y; Yokoo M; Kimura S; Andreeff M; Kojima K
Cancer Sci; 2014 Jul; 105(7):795-801. PubMed ID: 24766216
[TBL] [Abstract][Full Text] [Related]
68. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
[TBL] [Abstract][Full Text] [Related]
69. Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.
Kumar R; Blakemore SJ; Ellis CE; Petricoin EF; Pratt D; Macoritto M; Matthews AL; Loureiro JJ; Elliston K
BMC Genomics; 2010 Jul; 11():419. PubMed ID: 20604938
[TBL] [Abstract][Full Text] [Related]
70. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
[TBL] [Abstract][Full Text] [Related]
71. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.
Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
[TBL] [Abstract][Full Text] [Related]
72. FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density.
Qi W; Fitchev PS; Cornwell ML; Greenberg J; Cabe M; Weber CR; Roy HK; Crawford SE; Savkovic SD
J Biol Chem; 2013 Jun; 288(23):16274-16281. PubMed ID: 23603907
[TBL] [Abstract][Full Text] [Related]
73. Screening Health-Promoting Compounds for Their Capacity to Induce the Activity of FOXO3.
Jimenez L; Silva A; Calissi G; Grenho I; Monteiro R; Mayoral-Varo V; Blanco-Aparicio C; Pastor J; Bustos V; Bracher F; Megías D; Ferreira BI; Link W
J Gerontol A Biol Sci Med Sci; 2022 Aug; 77(8):1485-1493. PubMed ID: 34508571
[TBL] [Abstract][Full Text] [Related]
74. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
75. The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.
Shi C; Li X; Wang X; Ding N; Ping L; Shi Y; Mi L; Lai Y; Song Y; Zhu J
J Hematol Oncol; 2018 Mar; 11(1):43. PubMed ID: 29554921
[TBL] [Abstract][Full Text] [Related]
76. Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis.
Fusi L; Paudel R; Meder K; Schlosser A; Schrama D; Goebeler M; Schmidt M
J Biol Chem; 2022 Mar; 298(3):101714. PubMed ID: 35151693
[TBL] [Abstract][Full Text] [Related]
77. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
[TBL] [Abstract][Full Text] [Related]
78. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis.
Zhang F; Virshup DM; Cheong JK
Oncogene; 2018 Jan; 37(3):363-376. PubMed ID: 28945225
[TBL] [Abstract][Full Text] [Related]
79. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
Gao Z; Li Z; Liu Y; Liu Z
Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
[TBL] [Abstract][Full Text] [Related]
80. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
